Atul Ltd 2019-20

Corporate Overview Statutory Reports Financial Statements 01-21 22-91 92-228 106 Atul Ltd | Annual Report 2019-20 ( ` cr ) Particulars 2019-20 2018-19 C CASH FLOW FROM FINANCING ACTIVITIES Disbursements | (Repayments) of short-term borrowings (net ) - (0.01) Payments of unclaimed dividend (1.12) (0.20) Interest paid (2.35) (3.66) Dividend on equity shares (including dividend distribution tax) (150.22) (39.74) Net cash used in financing activities C (153.69) (43.61) Net increase | (decrease) in cash and cash equivalents A+B+C (9.96) (4.80) Cash and cash equivalents at the beginning of the year 15.39 20.19 Cash and cash equivalents at the end of the year 5.43 15.39 i) T he above Statement of Cash Flows has been prepared under the 'Indirect Method' as set out in the Ind AS 7 on the Statement of Cash Flows as notified under Companies (Indian Accounting Standards) Rules, 2015 as amended. ii) C ash flows fromoperating activities include ` 9.60 cr (March 31, 2019: ` 7.90 cr) being expenses towards Corporate Social Responsibility initiatives. iii) Refer Note 17 (f) for a reconciliation of changes in liabilities arising from financing activities. iv) O ptionally convertible cumulative redeemable preference shares of ` 20 cr were converted to equity shares of Atul Bioscience Ltd as per the conversion option in such shares during the year. The accompanying Notes 1-28 form an integral part of the Standalone Financial Statements Standalone Statement of Cash Flows for the year ended March 31, 2020 In terms of our report attached For Deloitte Haskins & Sells LLP For and on behalf of the Board of Directors Chartered Accountants Samir R. Shah T R Gopi Kannan S S Lalbhai Partner Whole-time Director and CFO Chairman and Managing Director L P Patni Company Secretary B N Mohanan Mumbai Whole-time Director Atul April 28, 2020 and President - U&S April 28, 2020